Is there an antagonistic pleiotropic effect of a LRRK2 mutation on leprosy and Parkinson’s disease?
Open Access
- 28 April 2020
- journal article
- letter
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (19) , 10122-10123
Abstract
No abstract availableKeywords
Funding Information
- Applied Basic Research Key Project of Yunnan Province (2019FA009 and 2019FI015)
- National Natural Science Foundation of China (8157303)
This publication has 10 references indexed in Scilit:
- Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson’s diseaseProceedings of the National Academy of Sciences, 2019
- LRRK2 regulates innate immune responses and neuroinflammation during Mycobacterium tuberculosis infectionbioRxiv, 2019
- Complement C7is a novel risk gene for Alzheimer's disease in Han ChineseNational Science Review, 2018
- Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulationMolecular Psychiatry, 2018
- Missense Variants in HIF1A and LACC1 Contribute to Leprosy Risk in Han ChineseThe American Journal of Human Genetics, 2018
- Leprosy type 1 reaction (formerly reversal reaction)Clinics in Dermatology, 2016
- Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest ChinaGenes & Immunity, 2014
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's diseaseNature Reviews Neuroscience, 2010
- Analysis of Lrrk2 R1628P as a risk factor for Parkinson's diseaseAnnals of Neurology, 2008
- Systemic infections and inflammation affect chronic neurodegenerationNature Reviews Immunology, 2007